|
1)Spellberg B:Dr. William H. Stewart;mistaken or maligned? Clin Infect Dis 47:294, 2008
|
|
|
|
2)Maki DG, Tambyah PA:Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7:342-347, 2001
|
|
|
|
|
|
3)日本泌尿器科学会泌尿器科領域における感染制御ガイドライン作成委員会:泌尿器科領域における感染制御ガイドライン.日泌会誌100:1-27,2009
|
|
|
|
|
4)Umscheid CA, Mitchell MD, Doschi JA et al:Estimating the proportion of infections that are reasonably preventable and the related mortality and cost. Infect Control Hosp Epidemiol 32:101-114, 2011
|
|
|
|
|
|
5)Duszyńska W, Rosenthal VD, Szczęsny A et al:Urinary tract infections in intensive care unit patients;a single-centre, 3-year observational study according to the INICC project. Anaesthesiol Intensive Ther 48:1-6, 2016
|
|
|
|
|
|
6)Kalanuria AA, Ziai W, Mirski M:Ventilator-associated pneumonia in the ICU. Crit Care 18:208, 2014
|
|
|
|
|
|
7)Cook DJ, Kollef MH:Risk factors for ICU-acquired pneumonia. JAMA 279:1605-1606, 1998
|
|
|
|
|
|
8)O'Horo JC, Thompson D, Safdar N:Is the Gram stain useful in the microbiologic diagnosis of VAP?;a meta-analysis. Clinical Infectious Diseases 55:551-561, 2012
|
|
|
|
|
|
9)Dimopoulos G, Poulakou G, Pneumatikos IA et al:Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia;a systematic review and meta-analysis. Chest 144:1759-1767, 2013
|
|
|
|
|
|
10)日本集中治療医学会ICU機能評価委員会:人工呼吸関連肺炎予防バンドル 2010改訂版.<http://www.jsicm.org/pdf/2010VAP.pdf>[Accessed 2016 Nov 22]
|
|
|
|
|
|
11)Steinberg JP, Robichaux C, Tejedor SC et al:Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy;evidence for a proposed modification to the current surveillance definition. Infect Control Hosp Epidemiol 34:171-175, 2013
|
|
|
|
|
|
12)Ziegler MJ, Pellegrini DC, Safdar N:Attributable mortality of central line associated bloodstream infection;systematic review and meta-analysis. Infection 43:29-36, 2015
|
|
|
|
|
|
13)Marschall J, Mermel LA, Fakih M et al:Strategies to prevent central line-associated bloodstream infections in acute care hospitals;2014 update. Infect Control Hosp Epidemiol 35:753-771, 2014
|
|
|
|
|
|
14)神谷 茂:ディフィシル菌感染症の基礎と臨床.モダンメディア56:233-241,2010
|
|
|
|
|
15)Balassiano IT, Dos Santos-Filho J, de Oliveira MP et al:An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil. Diagn Microbiol Infect Dis 68:449-455, 2010
|
|
|
|
|
|
16)Kyne L, Hamel MB, Polavaram R et al:Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34:346-353, 2002
|
|
|
|
|
|
17)Barlam TF, Cosgrove SE, Abbo LM et al:Implementing an Antibiotic Stewardship Program;guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62:e51-e77, 2016
|
|
|
|
|
|
18)一般社団法人日本感染症学会, 公益社団法人日本化学療法学会 JAID/JSC感染症治療ガイド･ガイドライン作成委員会 呼吸器感染症WG:委員会報告 JAID/JSC感染症治療ガイドライン─呼吸器感染症.感染症誌88:1-109,2014
|
|
|
|
|
|
19)CDC. Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta, GA:US Department of Health and Human Services, CDC; 2014. <http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html.re/implementation/core-elements.html>
|
|
|
|
|